Duployez N, Largeaud L, Duchmann M, Kim R, et al. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood 2022 Apr 20. pii: 485005. doi: 10.1182/blood.2021015328.
PMID: 35443031